Related Experiment Videos
[Primary sclerosing cholangitis--an ulcerative colitis-associated illness with surgical consequences]
G Heuschen1, U A Heuschen, C Herfarth
1Chirurgische Klinik und Poliklinik, Universität Heidelberg.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen
|December 2, 1998
Summary
Primary sclerosing cholangitis (PSC), often linked with ulcerative colitis (UC), progresses slowly, potentially causing liver failure or cancer. Effective treatments are lacking, but liver transplantation offers a good prognosis for advanced PSC.
Area of Science:
- Hepatology
- Gastroenterology
- Oncology
Context:
- Primary sclerosing cholangitis (PSC) is a rare, chronic liver disease.
- PSC frequently co-occurs with inflammatory bowel diseases, particularly ulcerative colitis (UC).
- The long-term prognosis for PSC is often poor, leading to complications like cirrhosis, liver failure, and bile duct cancer.
Purpose:
- To review the current understanding of primary sclerosing cholangitis (PSC).
- To discuss the association between PSC and ulcerative colitis (UC).
- To outline management strategies and treatment options for PSC.
Summary:
- PSC is a progressive liver disease associated with UC, increasing colorectal cancer risk.
- Current treatments for PSC are limited; ursodeoxycholic acid shows preliminary promise but requires further study.
- Endoscopic treatment for strictures and liver transplantation for end-stage disease are key management approaches.
Impact:
- Highlights the need for effective PSC treatments and improved patient outcomes.
- Emphasizes the importance of lifelong colonoscopic surveillance for UC patients, especially post-transplant.
- Underscores the significant survival benefit of liver transplantation for PSC patients.